• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 SOLITAIRE FR; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 SOLITAIRE FR; CATHETER, THROMBUS RETRIEVER Back to Search Results
Model Number UNK-NV-SFR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Date 03/01/2020
Event Type  Death  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Thomas r.Meinel, joachim u.Kniepert, david j.Seiffge, jan gralla, simon jung, elias auer, sebastién frey, martina goeldlin, pasquale mordasini, pascal j.Mosimann, raul g.Nogueira, diogo c.Haussen, gabriel m.Rodrigues, timo uphaus, vincent l¿allinec, dagmar krajícková, angelika alonso, vincent costalat, steven d.Hajdu, marta olivé-gadea, christian maegerlein, laurent pierot, joanna schaafsma, kentaro suzuki, marcel arnold, mirjam r.Heldner, urs fischer, johannes kaesmacher.Endovascular stroke treatment and risk of intracranial hemorrhage in anticoagulated patients.Stroke 51 (2020).Doi: 10.1161/strokeaha.119.026606 background and purpose¿we aimed to determine the safety and mortality after mechanical thrombectomy in patients taking vitamin k antagonists (vkas) or direct oral anticoagulants (doacs).Methods¿in a multicenter observational cohort study, we used multiple logistic regression analysis to evaluate associations of symptomatic intracranial hemorrhage (sich) with vka or doac prescription before thrombectomy as compared with no anticoagulation.The primary outcomes were the rate of sich and all-cause mortality at 90 days, incorporating sensitivity analysis regarding confirmed therapeutic anticoagulation.Additionally, we performed a systematic review and meta-analysis of literature on this topic.Results¿altogether, 1932 patients were included (vka, n=222; doac, n=98; no anticoagulation, n=1612); median age, 74 years (interquartile range, 62¿82); 49.6% women.Vka prescription was associated with increased odds for sich and mortality (adjusted odds ratio [aor], 2.55 [95% ci, 1.35¿4.84] and 1.64 [95% ci, 1.09¿2.47]) as compared with the control group, whereas no association with doac intake was observed (aor, 0.98 [95% ci, 0.29¿3.35] and 1.35 [95% ci, 0.72¿2.53]).Sensitivity analyses considering only patients within the confirmed therapeutic anticoagulation range did not alter the findings.A study-level meta-analysis incorporating data from 7462 patients (855 vkas, 318 doacs, and 6289 controls) from 15 observational cohorts corroborated these observations, yielding an increased rate of sich in vka patients (aor, 1.62 [95% ci, 1.22¿2.17]) but not in doac patients (aor, 1.03 [95% ci, 0.60¿1.80]).Conclusions¿patients taking vka have an increased risk of sich and mortality after mechanical thrombectomy.The lower risk of sich associated with doac may also be noticeable in the acute setting.Improved selection might be advisable in vka-treated patients.- 21 patients in the doac group, 64 patients in the vka group, and 347 patients with no oral anticoagulation had died at 3 months.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLITAIRE FR
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
david gustafson
9775 toledo way
irvine, CA 92618
7635149628
MDR Report Key11366296
MDR Text Key233091040
Report Number2029214-2021-00196
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeSZ
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 02/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/23/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-NV-SFR
Device Catalogue NumberUNK-NV-SFR
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/06/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-